Finland· FI-REL-REL52162
Delstrigo
A lamivudine, tenofovir disoproxil and doravirine product containing doravirine + lamivudine + tenofovir disoproxil fumarate, registered in Finland by Merck Sharp & Dohme B.V.. The same ATC class is registered in 13 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Lamivudine, tenofovir disoproxil and doravirine is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AR24 (lamivudine, tenofovir disoproxil and doravirine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 8 of them publish a price we can compare per daily dose
Lamivudine, tenofovir disoproxil and doravirine · ATC J05AR24
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
Fimea (Finland)- Active substance
- Doravirine + Lamivudine + Tenofovir disoproxil fumarate
- Manufacturer
- Merck Sharp & Dohme B.V.
- Country
- Finland (FI)
- ATC code
- J05AR24
- ATC class
- Lamivudine, tenofovir disoproxil and doravirine
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 1
1 priced- fi_myyntilupa07392830EUR 1216.27
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lamivudine, tenofovir disoproxil and doravirine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaDELSTRIGOMerck Sharp & Dohme B.V., Haarlem
- United StatesDELSTRIGOMerck Sharp & Dohme LLC
- FranceDELSTRIGO 100 mg/300 mg/245 mg, comprimé pelliculéMERCK SHARP & DOHME (PAYS-BAS)
- United KingdomDelstrigo 100mg/300mg/245mg tabletsMerck Sharp & Dohme (UK) Ltd
- CanadaDELSTRIGOMERCK CANADA INC
- IcelandDelstrigoMerck Sharp & Dohme B.V.*
- NorwayDelstrigoMerck Sharp & Dohme Ltd (1)
- PolandDelstrigoMerck Sharp & Dohme B.V.
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Delstrigo
- Liechtenstein · Delstrigo
- Norway · Delstrigo
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0420ec42-6193-46e3-88c8-9fa25f89c8ab GET /v1/drugs/0420ec42-6193-46e3-88c8-9fa25f89c8ab?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "1",
"form": "tabletti, kalvopäällysteinen",
"route": "Suun kautta",
"ddd_unit": "ED",
"strength": "100 mg / 300 mg / 245 mg",
"atc_label": "lamivudiini, tenofoviiridisoproksiili ja doraviriini",
"ma_number": null,
"auth_status": "Myyntilupa myönnetty",
"eu_ma_number": "EU/1/18/1333/001-002",
"fimea_rel_id": "REL52162",
"authorised_at": "2018-11-22"
}See everything about lamivudine, tenofovir disoproxil and doravirine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.